

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 6.95251823 |
| 2 | regulation of platelet activation (GO:0010543) | 5.44173250 |
| 3 | regulation of platelet aggregation (GO:0090330) | 5.25815704 |
| 4 | protein neddylation (GO:0045116) | 4.82914199 |
| 5 | positive regulation of mast cell activation (GO:0033005) | 4.65247236 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.63607733 |
| 7 | regulation of integrin activation (GO:0033623) | 4.55818866 |
| 8 | adenosine receptor signaling pathway (GO:0001973) | 4.49241664 |
| 9 | negative regulation of platelet activation (GO:0010544) | 4.42669350 |
| 10 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.32643875 |
| 11 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.30201506 |
| 12 | endothelium development (GO:0003158) | 4.24702245 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.24435067 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.83761167 |
| 15 | lipoxygenase pathway (GO:0019372) | 3.76271749 |
| 16 | platelet degranulation (GO:0002576) | 3.68047506 |
| 17 | megakaryocyte development (GO:0035855) | 3.66710052 |
| 18 | negative regulation of norepinephrine secretion (GO:0010700) | 3.62459393 |
| 19 | blood coagulation, intrinsic pathway (GO:0007597) | 3.61665309 |
| 20 | positive regulation of receptor recycling (GO:0001921) | 3.61100970 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.59096689 |
| 22 | regulation of mast cell activation (GO:0033003) | 3.52729041 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.46374285 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46374285 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.46374285 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46374285 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46374285 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46374285 |
| 29 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.45834632 |
| 30 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.45715809 |
| 31 | positive regulation of hemostasis (GO:1900048) | 3.45680240 |
| 32 | positive regulation of blood coagulation (GO:0030194) | 3.45680240 |
| 33 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.41891447 |
| 34 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.38361626 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 3.37467193 |
| 36 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.37295305 |
| 37 | cell adhesion mediated by integrin (GO:0033627) | 3.35202154 |
| 38 | positive regulation of mast cell degranulation (GO:0043306) | 3.30743448 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.30743448 |
| 40 | platelet activation (GO:0030168) | 3.29504656 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.27800917 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.26760846 |
| 43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26760846 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23531494 |
| 45 | phagocytosis, engulfment (GO:0006911) | 3.22389782 |
| 46 | low-density lipoprotein particle remodeling (GO:0034374) | 3.19477736 |
| 47 | positive regulation of coagulation (GO:0050820) | 3.18643717 |
| 48 | homotypic cell-cell adhesion (GO:0034109) | 3.18204268 |
| 49 | positive regulation of interferon-alpha production (GO:0032727) | 3.16595113 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15713018 |
| 51 | platelet formation (GO:0030220) | 3.13609618 |
| 52 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.13486979 |
| 53 | cellular extravasation (GO:0045123) | 3.08832815 |
| 54 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.07461860 |
| 55 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04099716 |
| 56 | peptide catabolic process (GO:0043171) | 3.03242295 |
| 57 | response to peptidoglycan (GO:0032494) | 3.01834579 |
| 58 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.00719378 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.00719378 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 2.98952538 |
| 61 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.92844663 |
| 62 | regulation of lipoprotein metabolic process (GO:0050746) | 2.92810328 |
| 63 | negative regulation of lipid storage (GO:0010888) | 2.92399049 |
| 64 | negative regulation of interleukin-17 production (GO:0032700) | 2.92288511 |
| 65 | negative regulation of cell junction assembly (GO:1901889) | 2.91749094 |
| 66 | negative regulation of adherens junction organization (GO:1903392) | 2.91749094 |
| 67 | negative regulation of focal adhesion assembly (GO:0051895) | 2.91749094 |
| 68 | leukocyte degranulation (GO:0043299) | 2.89776431 |
| 69 | extracellular fibril organization (GO:0043206) | 2.85608068 |
| 70 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.85308142 |
| 71 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.85210136 |
| 72 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84491511 |
| 73 | superoxide anion generation (GO:0042554) | 2.84064895 |
| 74 | negative regulation of stress fiber assembly (GO:0051497) | 2.82615972 |
| 75 | purinergic receptor signaling pathway (GO:0035587) | 2.81272408 |
| 76 | cellular response to zinc ion (GO:0071294) | 2.81056704 |
| 77 | regulation of blood coagulation (GO:0030193) | 2.78516739 |
| 78 | regulation of hemostasis (GO:1900046) | 2.78516739 |
| 79 | autophagic vacuole fusion (GO:0000046) | 2.78369295 |
| 80 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.77981358 |
| 81 | positive regulation of leukocyte degranulation (GO:0043302) | 2.77890643 |
| 82 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.77866238 |
| 83 | membrane invagination (GO:0010324) | 2.77582709 |
| 84 | leukocyte aggregation (GO:0070486) | 2.74723902 |
| 85 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.74337522 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 2.74113061 |
| 87 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.72873858 |
| 88 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.72716674 |
| 89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72523851 |
| 90 | neutrophil activation (GO:0042119) | 2.72153376 |
| 91 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.71755797 |
| 92 | response to interferon-alpha (GO:0035455) | 2.71723096 |
| 93 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.71701011 |
| 94 | mesodermal cell differentiation (GO:0048333) | 2.69788865 |
| 95 | cellular response to interferon-alpha (GO:0035457) | 2.67925073 |
| 96 | endodermal cell differentiation (GO:0035987) | 2.66286226 |
| 97 | positive regulation of granulocyte differentiation (GO:0030854) | 2.66015198 |
| 98 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.65993645 |
| 99 | immunoglobulin mediated immune response (GO:0016064) | 2.63946902 |
| 100 | cyclooxygenase pathway (GO:0019371) | 2.63471636 |
| 101 | regulation of leukocyte degranulation (GO:0043300) | 2.63462994 |
| 102 | fibril organization (GO:0097435) | 2.63413346 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.62719940 |
| 104 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.62130748 |
| 105 | regulation of coagulation (GO:0050818) | 2.61329753 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.60845811 |
| 107 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60459880 |
| 108 | endothelial tube morphogenesis (GO:0061154) | 2.59142661 |
| 109 | morphogenesis of an endothelium (GO:0003159) | 2.59142661 |
| 110 | pinocytosis (GO:0006907) | 2.58934816 |
| 111 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.57405391 |
| 112 | positive regulation of B cell differentiation (GO:0045579) | 2.57382306 |
| 113 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.57278629 |
| 114 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.57111785 |
| 115 | myeloid cell development (GO:0061515) | 2.55336938 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.55102629 |
| 117 | negative regulation of phagocytosis (GO:0050765) | 2.54880960 |
| 118 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.54131618 |
| 119 | substrate-dependent cell migration (GO:0006929) | 2.54010030 |
| 120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53630073 |
| 121 | wound healing, spreading of epidermal cells (GO:0035313) | 2.51988110 |
| 122 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51033695 |
| 123 | granulocyte activation (GO:0036230) | 2.50497329 |
| 124 | establishment of endothelial barrier (GO:0061028) | 2.50164910 |
| 125 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.46855381 |
| 126 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.46755726 |
| 127 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46666144 |
| 128 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40413301 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.36339012 |
| 130 | B cell mediated immunity (GO:0019724) | 2.36185018 |
| 131 | regulation of necroptotic process (GO:0060544) | 2.35841390 |
| 132 | lymph vessel development (GO:0001945) | 2.35134023 |
| 133 | angiogenesis involved in wound healing (GO:0060055) | 2.34702408 |
| 134 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.33213329 |
| 135 | natural killer cell mediated immunity (GO:0002228) | 2.33213329 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32699369 |
| 137 | response to host immune response (GO:0052572) | 2.32313094 |
| 138 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.32313094 |
| 139 | positive regulation of macrophage differentiation (GO:0045651) | 2.32184960 |
| 140 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.31854853 |
| 141 | response to type I interferon (GO:0034340) | 2.31070519 |
| 142 | leukocyte cell-cell adhesion (GO:0007159) | 2.29756572 |
| 143 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.29680693 |
| 144 | hepatocyte apoptotic process (GO:0097284) | 2.28277208 |
| 145 | positive regulation of vasculogenesis (GO:2001214) | 2.27233216 |
| 146 | integrin-mediated signaling pathway (GO:0007229) | 2.26433297 |
| 147 | membrane raft organization (GO:0031579) | 2.26180069 |
| 148 | response to laminar fluid shear stress (GO:0034616) | 2.26119712 |
| 149 | type I interferon signaling pathway (GO:0060337) | 2.25804591 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.25804591 |
| 151 | regulation of protein heterodimerization activity (GO:0043497) | 2.25058678 |
| 152 | definitive hemopoiesis (GO:0060216) | 2.24657733 |
| 153 | positive regulation of interferon-beta production (GO:0032728) | 2.24598863 |
| 154 | respiratory burst (GO:0045730) | 2.23544543 |
| 155 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.23456014 |
| 156 | response to host (GO:0075136) | 2.22647158 |
| 157 | response to host defenses (GO:0052200) | 2.22647158 |
| 158 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.22647158 |
| 159 | positive regulation of lamellipodium assembly (GO:0010592) | 2.21080513 |
| 160 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.20509216 |
| 161 | response to interferon-beta (GO:0035456) | 2.19835809 |
| 162 | actin nucleation (GO:0045010) | 2.19820963 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.19094106 |
| 164 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.18126661 |
| 165 | cellular response to interferon-beta (GO:0035458) | 2.17430605 |
| 166 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.16172238 |
| 167 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.15886312 |
| 168 | wound healing, spreading of cells (GO:0044319) | 2.14657600 |
| 169 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.14545616 |
| 170 | collagen fibril organization (GO:0030199) | 2.14272154 |
| 171 | germ cell migration (GO:0008354) | 2.13140259 |
| 172 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.12643072 |
| 173 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.12502067 |
| 174 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.12467248 |
| 175 | regulation of macrophage cytokine production (GO:0010935) | 2.10766739 |
| 176 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.10708645 |
| 177 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.10701799 |
| 178 | sequestering of metal ion (GO:0051238) | 2.10691894 |
| 179 | regulation of chemokine biosynthetic process (GO:0045073) | 2.09631951 |
| 180 | platelet aggregation (GO:0070527) | 2.08742227 |
| 181 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.07648861 |
| 182 | glomerular filtration (GO:0003094) | 2.07560648 |
| 183 | apoptotic cell clearance (GO:0043277) | 2.07505208 |
| 184 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.07103367 |
| 185 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.06684423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.72629770 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.07701351 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.06741300 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.98170972 |
| 5 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.60944227 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.57457948 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40982666 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.29844339 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.24181564 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93730801 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.87337182 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71876652 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65202977 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62897758 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.60541415 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51873045 |
| 17 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.50818424 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50263581 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45785922 |
| 20 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.40419314 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39090246 |
| 22 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.28110212 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.25474893 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.21423492 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.19833557 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17745447 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12753216 |
| 28 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.09628149 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05574138 |
| 30 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.99711636 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.98624269 |
| 32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90623315 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88527909 |
| 34 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.87624581 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85721870 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85620777 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83897872 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.82828518 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81113715 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.79975878 |
| 41 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79069262 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74643487 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73826582 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73066755 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70784881 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.63740891 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63672929 |
| 48 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60778566 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58973347 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57879021 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56521787 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54896864 |
| 53 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53561552 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50886637 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50874426 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50228185 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50228185 |
| 58 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.50022418 |
| 59 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47422986 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47201989 |
| 61 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46386280 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.46285780 |
| 63 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46158386 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45801296 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45561425 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.45506295 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42640369 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.41322267 |
| 69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.41322267 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40224297 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.40104197 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37055885 |
| 73 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35120487 |
| 74 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33553349 |
| 75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33046960 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32934849 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.30712966 |
| 78 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29962589 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29625523 |
| 80 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.29571872 |
| 81 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28128189 |
| 82 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27174950 |
| 83 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.27059411 |
| 84 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26631683 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23540772 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23250089 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19028226 |
| 88 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.17930124 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17074852 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15231456 |
| 91 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14684049 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13995311 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13202988 |
| 94 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12964263 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11019450 |
| 96 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10739142 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10417526 |
| 98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10129929 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09667687 |
| 100 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.09541944 |
| 101 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08829588 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06482880 |
| 103 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06456084 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06406871 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05942405 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05195105 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04760401 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03359911 |
| 109 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.99525672 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99186701 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98355337 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97552407 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96630178 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96508855 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95968620 |
| 116 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95605487 |
| 117 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95569537 |
| 118 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95309660 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94982827 |
| 120 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93399017 |
| 121 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92953605 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92874094 |
| 123 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92512894 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91648695 |
| 125 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90885220 |
| 126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90343775 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89571463 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87418377 |
| 129 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87336201 |
| 130 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.87292454 |
| 131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86688375 |
| 132 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86565077 |
| 133 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86313335 |
| 134 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85013909 |
| 135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.82541416 |
| 136 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79692576 |
| 137 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77144008 |
| 138 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.75205709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 3.96102601 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.65782115 |
| 3 | MP0006054_spinal_hemorrhage | 2.77928935 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.48734397 |
| 5 | MP0003279_aneurysm | 2.48650034 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.16951076 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.13012587 |
| 8 | MP0009785_altered_susceptibility_to | 2.09046814 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.01273773 |
| 10 | MP0001958_emphysema | 2.00786162 |
| 11 | MP0005275_abnormal_skin_tensile | 1.96121768 |
| 12 | MP0003436_decreased_susceptibility_to | 1.92104591 |
| 13 | MP0001879_abnormal_lymphatic_vessel | 1.90393101 |
| 14 | MP0003300_gastrointestinal_ulcer | 1.87213099 |
| 15 | MP0005503_abnormal_tendon_morphology | 1.84347569 |
| 16 | MP0009278_abnormal_bone_marrow | 1.82380524 |
| 17 | MP0002166_altered_tumor_susceptibility | 1.82034683 |
| 18 | MP0003724_increased_susceptibility_to | 1.80260020 |
| 19 | MP0000685_abnormal_immune_system | 1.80137153 |
| 20 | MP0004272_abnormal_basement_membrane | 1.78483399 |
| 21 | MP0003303_peritoneal_inflammation | 1.74410579 |
| 22 | MP0002419_abnormal_innate_immunity | 1.70089548 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 1.66141309 |
| 24 | MP0002396_abnormal_hematopoietic_system | 1.63736964 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.61486936 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.59486537 |
| 27 | MP0002006_tumorigenesis | 1.59017495 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.58334113 |
| 29 | MP0004084_abnormal_cardiac_muscle | 1.54902927 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.54655096 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.52617233 |
| 32 | MP0004036_abnormal_muscle_relaxation | 1.51183751 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.50610026 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.50610026 |
| 35 | MP0000767_abnormal_smooth_muscle | 1.49650268 |
| 36 | * MP0000343_altered_response_to | 1.48907870 |
| 37 | MP0005025_abnormal_response_to | 1.47388302 |
| 38 | MP0003091_abnormal_cell_migration | 1.46114409 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.45255685 |
| 40 | MP0001851_eye_inflammation | 1.44476104 |
| 41 | MP0010307_abnormal_tumor_latency | 1.44146257 |
| 42 | MP0005023_abnormal_wound_healing | 1.43324266 |
| 43 | MP0005671_abnormal_response_to | 1.43191633 |
| 44 | MP0000230_abnormal_systemic_arterial | 1.40359566 |
| 45 | MP0003448_altered_tumor_morphology | 1.40106115 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.39883393 |
| 47 | * MP0003828_pulmonary_edema | 1.37902200 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.37225476 |
| 49 | MP0004130_abnormal_muscle_cell | 1.35434483 |
| 50 | MP0001800_abnormal_humoral_immune | 1.34262425 |
| 51 | MP0001790_abnormal_immune_system | 1.33923581 |
| 52 | MP0005387_immune_system_phenotype | 1.33923581 |
| 53 | MP0001819_abnormal_immune_cell | 1.33579221 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.32666273 |
| 55 | MP0001853_heart_inflammation | 1.30739301 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.29678379 |
| 57 | MP0002405_respiratory_system_inflammati | 1.27465592 |
| 58 | MP0000733_abnormal_muscle_development | 1.27318221 |
| 59 | MP0002723_abnormal_immune_serum | 1.26907355 |
| 60 | MP0000858_altered_metastatic_potential | 1.25705634 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.25397469 |
| 62 | MP0005165_increased_susceptibility_to | 1.23573020 |
| 63 | MP0003075_altered_response_to | 1.23525427 |
| 64 | MP0009763_increased_sensitivity_to | 1.22975886 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.22475588 |
| 66 | MP0009384_cardiac_valve_regurgitation | 1.21998272 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.21764426 |
| 68 | MP0006082_CNS_inflammation | 1.19988790 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.18410073 |
| 70 | MP0002398_abnormal_bone_marrow | 1.15171260 |
| 71 | MP0004947_skin_inflammation | 1.15036200 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.12211481 |
| 73 | MP0009840_abnormal_foam_cell | 1.12049738 |
| 74 | MP0004883_abnormal_blood_vessel | 1.10072150 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.09577158 |
| 76 | MP0001663_abnormal_digestive_system | 1.08850255 |
| 77 | MP0002933_joint_inflammation | 1.08438199 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.07886249 |
| 79 | MP0003950_abnormal_plasma_membrane | 1.06907615 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.06757894 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.06475579 |
| 82 | MP0005083_abnormal_biliary_tract | 1.05229172 |
| 83 | MP0001915_intracranial_hemorrhage | 1.03926663 |
| 84 | MP0000716_abnormal_immune_system | 1.03433342 |
| 85 | MP0005390_skeleton_phenotype | 1.02867407 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.00592987 |
| 87 | * MP0010630_abnormal_cardiac_muscle | 0.98589691 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.96296662 |
| 89 | MP0002128_abnormal_blood_circulation | 0.95537627 |
| 90 | MP0000750_abnormal_muscle_regeneration | 0.95246415 |
| 91 | MP0008775_abnormal_heart_ventricle | 0.94915011 |
| 92 | MP0000015_abnormal_ear_pigmentation | 0.94872608 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.94638393 |
| 94 | MP0004484_altered_response_of | 0.94585382 |
| 95 | MP0002429_abnormal_blood_cell | 0.94339407 |
| 96 | MP0002722_abnormal_immune_system | 0.94035304 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.93955935 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.93768722 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93471003 |
| 100 | MP0008007_abnormal_cellular_replicative | 0.93390198 |
| 101 | MP0004510_myositis | 0.92075458 |
| 102 | MP0005166_decreased_susceptibility_to | 0.90932284 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.90789615 |
| 104 | * MP0000249_abnormal_blood_vessel | 0.86934749 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.86816822 |
| 106 | MP0002925_abnormal_cardiovascular_devel | 0.86241240 |
| 107 | MP0005164_abnormal_response_to | 0.86028014 |
| 108 | * MP0001614_abnormal_blood_vessel | 0.84935801 |
| 109 | MP0002132_abnormal_respiratory_system | 0.84117226 |
| 110 | MP0008469_abnormal_protein_level | 0.83880108 |
| 111 | MP0009764_decreased_sensitivity_to | 0.80700866 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.80617083 |
| 113 | MP0000490_abnormal_crypts_of | 0.79859932 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.79657884 |
| 115 | MP0005410_abnormal_fertilization | 0.77908653 |
| 116 | MP0005409_darkened_coat_color | 0.77548382 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.76547356 |
| 118 | MP0002060_abnormal_skin_morphology | 0.76538341 |
| 119 | * MP0001544_abnormal_cardiovascular_syste | 0.75866115 |
| 120 | * MP0005385_cardiovascular_system_phenoty | 0.75866115 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.74854485 |
| 122 | MP0003795_abnormal_bone_structure | 0.74339653 |
| 123 | MP0008874_decreased_physiological_sensi | 0.73862303 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.72636573 |
| 125 | MP0003806_abnormal_nucleotide_metabolis | 0.71045256 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.70370416 |
| 127 | MP0001243_abnormal_dermal_layer | 0.70181284 |
| 128 | * MP0002972_abnormal_cardiac_muscle | 0.70079519 |
| 129 | MP0001873_stomach_inflammation | 0.69999810 |
| 130 | MP0003045_fibrosis | 0.69376738 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.68800632 |
| 132 | MP0009697_abnormal_copulation | 0.67804793 |
| 133 | MP0010329_abnormal_lipoprotein_level | 0.65238741 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.64755757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.49405508 |
| 2 | Menorrhagia (HP:0000132) | 8.11125229 |
| 3 | Purpura (HP:0000979) | 7.26116012 |
| 4 | Epistaxis (HP:0000421) | 6.65925008 |
| 5 | Gingival bleeding (HP:0000225) | 5.65486336 |
| 6 | Impaired platelet aggregation (HP:0003540) | 5.32919298 |
| 7 | Abnormal platelet function (HP:0011869) | 5.32919298 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.24922095 |
| 9 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 4.02459382 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.96402802 |
| 11 | Conjunctival telangiectasia (HP:0000524) | 3.93152452 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.80678293 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.79793008 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.68754527 |
| 15 | Hematochezia (HP:0002573) | 3.63417529 |
| 16 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.33645128 |
| 17 | Osteolytic defects of the hand bones (HP:0009699) | 3.33645128 |
| 18 | Aortic aneurysm (HP:0004942) | 3.27032856 |
| 19 | Aortic dissection (HP:0002647) | 3.24660910 |
| 20 | Bruising susceptibility (HP:0000978) | 3.24147903 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 3.21956645 |
| 22 | Myocardial infarction (HP:0001658) | 3.14738056 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.14113543 |
| 24 | Poikilocytosis (HP:0004447) | 3.12551506 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.03284239 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00760410 |
| 27 | Dyschromatopsia (HP:0007641) | 2.99916766 |
| 28 | Ankle contracture (HP:0006466) | 2.97150926 |
| 29 | Cervical subluxation (HP:0003308) | 2.96540710 |
| 30 | Acanthocytosis (HP:0001927) | 2.94648610 |
| 31 | Stomatitis (HP:0010280) | 2.93351302 |
| 32 | Paralysis (HP:0003470) | 2.92326764 |
| 33 | Myositis (HP:0100614) | 2.87300919 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.85732369 |
| 35 | Peritonitis (HP:0002586) | 2.84756641 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.79623164 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.79623164 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.79623164 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.77649877 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70372806 |
| 41 | Polycythemia (HP:0001901) | 2.69732873 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.57561220 |
| 43 | Dilatation of the ascending aorta (HP:0005111) | 2.53765594 |
| 44 | Abnormality of macrophages (HP:0004311) | 2.51427058 |
| 45 | Abnormality of iron homeostasis (HP:0011031) | 2.49716824 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.49139084 |
| 47 | Soft skin (HP:0000977) | 2.46962321 |
| 48 | Cellulitis (HP:0100658) | 2.40460433 |
| 49 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.38125869 |
| 50 | Tinnitus (HP:0000360) | 2.37450016 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.35130942 |
| 52 | Increased connective tissue (HP:0009025) | 2.33166861 |
| 53 | Shallow orbits (HP:0000586) | 2.32327137 |
| 54 | Orchitis (HP:0100796) | 2.31217846 |
| 55 | Syringomyelia (HP:0003396) | 2.28830960 |
| 56 | Spinal cord lesions (HP:0100561) | 2.28830960 |
| 57 | Increased serum ferritin (HP:0003281) | 2.28090435 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.24196290 |
| 59 | Increased density of long bones (HP:0006392) | 2.24100010 |
| 60 | Abnormal pupillary function (HP:0007686) | 2.24075878 |
| 61 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.23656066 |
| 62 | Asymmetry of the thorax (HP:0001555) | 2.22407198 |
| 63 | Joint swelling (HP:0001386) | 2.21673121 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.19958520 |
| 65 | Vascular tortuosity (HP:0004948) | 2.19383819 |
| 66 | Short 4th metacarpal (HP:0010044) | 2.18189304 |
| 67 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.18189304 |
| 68 | Recurrent viral infections (HP:0004429) | 2.14427011 |
| 69 | Wormian bones (HP:0002645) | 2.13871765 |
| 70 | Xanthomatosis (HP:0000991) | 2.12649555 |
| 71 | Bicuspid aortic valve (HP:0001647) | 2.12078008 |
| 72 | Broad metatarsal (HP:0001783) | 2.12022672 |
| 73 | Nausea (HP:0002018) | 2.10855355 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.10163186 |
| 75 | Thrombocytosis (HP:0001894) | 2.09089708 |
| 76 | Spondylolisthesis (HP:0003302) | 2.07912954 |
| 77 | Atrophic scars (HP:0001075) | 2.06425377 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03382615 |
| 79 | Abnormality of the peritoneum (HP:0002585) | 2.03027856 |
| 80 | Mitral valve prolapse (HP:0001634) | 2.02442301 |
| 81 | Arterial tortuosity (HP:0005116) | 2.02376426 |
| 82 | Arterial thrombosis (HP:0004420) | 2.01932682 |
| 83 | Cerebral hemorrhage (HP:0001342) | 2.01703241 |
| 84 | Upper limb muscle weakness (HP:0003484) | 2.01329216 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 2.00983234 |
| 86 | Subacute progressive viral hepatitis (HP:0006572) | 2.00877543 |
| 87 | Persistence of primary teeth (HP:0006335) | 2.00138865 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.98483318 |
| 89 | Abnormality of lateral ventricle (HP:0030047) | 1.97561489 |
| 90 | Bladder diverticulum (HP:0000015) | 1.97424278 |
| 91 | Broad face (HP:0000283) | 1.95102414 |
| 92 | Abnormality of the prostate (HP:0008775) | 1.94447366 |
| 93 | Osteomyelitis (HP:0002754) | 1.93763693 |
| 94 | Gingivitis (HP:0000230) | 1.92058053 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91775748 |
| 96 | Chronic otitis media (HP:0000389) | 1.90220589 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.90127246 |
| 98 | Amaurosis fugax (HP:0100576) | 1.89905981 |
| 99 | Cutaneous melanoma (HP:0012056) | 1.89003251 |
| 100 | Joint hemorrhage (HP:0005261) | 1.88955943 |
| 101 | Retrobulbar optic neuritis (HP:0100654) | 1.88415695 |
| 102 | Optic neuritis (HP:0100653) | 1.88415695 |
| 103 | Increased IgM level (HP:0003496) | 1.87111737 |
| 104 | Recurrent skin infections (HP:0001581) | 1.86685500 |
| 105 | Radial bowing (HP:0002986) | 1.86484315 |
| 106 | Basal ganglia calcification (HP:0002135) | 1.86000111 |
| 107 | Increased mean platelet volume (HP:0011877) | 1.85982653 |
| 108 | Camptodactyly of toe (HP:0001836) | 1.84653181 |
| 109 | Biconcave vertebral bodies (HP:0004586) | 1.83848002 |
| 110 | Wrist flexion contracture (HP:0001239) | 1.82963790 |
| 111 | Blue sclerae (HP:0000592) | 1.82809785 |
| 112 | Type 1 muscle fiber predominance (HP:0003803) | 1.82684893 |
| 113 | Encephalitis (HP:0002383) | 1.81871203 |
| 114 | Papillary thyroid carcinoma (HP:0002895) | 1.81149627 |
| 115 | Absent frontal sinuses (HP:0002688) | 1.81102526 |
| 116 | Vertigo (HP:0002321) | 1.80721454 |
| 117 | Abnormality of the calcaneus (HP:0008364) | 1.80348853 |
| 118 | Chest pain (HP:0100749) | 1.78965652 |
| 119 | Mucosal telangiectasiae (HP:0100579) | 1.77695039 |
| 120 | Nonimmune hydrops fetalis (HP:0001790) | 1.77314972 |
| 121 | Joint contractures involving the joints of the feet (HP:0100492) | 1.77020059 |
| 122 | Flexion contracture of toe (HP:0005830) | 1.77020059 |
| 123 | Leukocytosis (HP:0001974) | 1.76834342 |
| 124 | Tetraparesis (HP:0002273) | 1.76821821 |
| 125 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.76418990 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76373349 |
| 127 | Aneurysm (HP:0002617) | 1.74864735 |
| 128 | Mitral regurgitation (HP:0001653) | 1.74745114 |
| 129 | Mitral stenosis (HP:0001718) | 1.74154118 |
| 130 | Eosinophilia (HP:0001880) | 1.71708113 |
| 131 | Genu recurvatum (HP:0002816) | 1.70534689 |
| 132 | T lymphocytopenia (HP:0005403) | 1.70523839 |
| 133 | Periodontitis (HP:0000704) | 1.70357482 |
| 134 | Muscle fibrillation (HP:0010546) | 1.69857172 |
| 135 | Petechiae (HP:0000967) | 1.69523528 |
| 136 | Spinal rigidity (HP:0003306) | 1.69143728 |
| 137 | Cerebral ischemia (HP:0002637) | 1.68147440 |
| 138 | Abnormal auditory evoked potentials (HP:0006958) | 1.67798025 |
| 139 | Lipoatrophy (HP:0100578) | 1.66966160 |
| 140 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.66771064 |
| 141 | Obstructive lung disease (HP:0006536) | 1.66373305 |
| 142 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66373305 |
| 143 | Portal hypertension (HP:0001409) | 1.65471963 |
| 144 | Tongue fasciculations (HP:0001308) | 1.62577326 |
| 145 | Vasculitis (HP:0002633) | 1.61282528 |
| 146 | Episodic fever (HP:0001954) | 1.60628724 |
| 147 | Distal lower limb amyotrophy (HP:0008944) | 1.60450711 |
| 148 | Fragile skin (HP:0001030) | 1.60378855 |
| 149 | Ulnar bowing (HP:0003031) | 1.60362351 |
| 150 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.59317614 |
| 151 | Follicular hyperkeratosis (HP:0007502) | 1.58531977 |
| 152 | Emphysema (HP:0002097) | 1.57865553 |
| 153 | Thrombophlebitis (HP:0004418) | 1.57738564 |
| 154 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.57344595 |
| 155 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.56979326 |
| 156 | Systemic lupus erythematosus (HP:0002725) | 1.56821398 |
| 157 | Acute myeloid leukemia (HP:0004808) | 1.56664873 |
| 158 | High pitched voice (HP:0001620) | 1.56092009 |
| 159 | Abnormality of T cell number (HP:0011839) | 1.55033649 |
| 160 | Skin ulcer (HP:0200042) | 1.54644240 |
| 161 | Abnormality of the pericardium (HP:0001697) | 1.54231873 |
| 162 | Loss of speech (HP:0002371) | 1.53098056 |
| 163 | Generalized aminoaciduria (HP:0002909) | 1.51021899 |
| 164 | Arthralgia (HP:0002829) | 1.46826701 |
| 165 | Male infertility (HP:0003251) | 1.46685134 |
| 166 | Abnormality of the hepatic vasculature (HP:0006707) | 1.46547627 |
| 167 | Esophageal varix (HP:0002040) | 1.46323606 |
| 168 | Decreased central vision (HP:0007663) | 1.45072497 |
| 169 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.44777695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.37367683 |
| 2 | TTN | 3.49142424 |
| 3 | BMX | 2.80677505 |
| 4 | TAOK3 | 2.46659059 |
| 5 | TGFBR2 | 2.25448016 |
| 6 | PTK2B | 2.11189578 |
| 7 | KDR | 2.10488119 |
| 8 | PKN2 | 2.10265700 |
| 9 | TRIB3 | 2.06071816 |
| 10 | BMPR2 | 2.05627865 |
| 11 | NEK9 | 2.05241338 |
| 12 | LRRK2 | 2.04226514 |
| 13 | JAK3 | 2.01997114 |
| 14 | MAP3K14 | 1.97851644 |
| 15 | TYK2 | 1.90273844 |
| 16 | STK10 | 1.90059408 |
| 17 | TBK1 | 1.88966431 |
| 18 | MAP4K1 | 1.86437403 |
| 19 | FGR | 1.86026095 |
| 20 | KIT | 1.82902854 |
| 21 | TGFBR1 | 1.76528615 |
| 22 | RPS6KA4 | 1.74729500 |
| 23 | FES | 1.71105428 |
| 24 | TIE1 | 1.70748487 |
| 25 | TRPM7 | 1.65818568 |
| 26 | PAK4 | 1.61280427 |
| 27 | SCYL2 | 1.54790137 |
| 28 | TEC | 1.52110673 |
| 29 | EPHB1 | 1.48250232 |
| 30 | NME2 | 1.44778764 |
| 31 | PTK6 | 1.43709248 |
| 32 | FLT3 | 1.43468410 |
| 33 | CSF1R | 1.38368833 |
| 34 | STK4 | 1.37773714 |
| 35 | MAP2K3 | 1.32721153 |
| 36 | ADRBK2 | 1.32006053 |
| 37 | FGFR3 | 1.31553348 |
| 38 | FRK | 1.27690888 |
| 39 | TESK1 | 1.27590903 |
| 40 | JAK1 | 1.25567500 |
| 41 | MYLK | 1.25295587 |
| 42 | IRAK4 | 1.24766368 |
| 43 | MAPKAPK3 | 1.23790517 |
| 44 | STK3 | 1.22266375 |
| 45 | DMPK | 1.21957101 |
| 46 | ZAP70 | 1.20171612 |
| 47 | IKBKB | 1.19402383 |
| 48 | PDGFRA | 1.19363507 |
| 49 | LATS1 | 1.19183126 |
| 50 | ERN1 | 1.16342586 |
| 51 | NUAK1 | 1.15206583 |
| 52 | EPHA3 | 1.12826597 |
| 53 | EEF2K | 1.12472546 |
| 54 | BTK | 1.10868450 |
| 55 | IKBKE | 1.08639527 |
| 56 | PIM2 | 1.07843511 |
| 57 | CSK | 1.07176586 |
| 58 | ITK | 1.06824298 |
| 59 | IRAK1 | 1.06206454 |
| 60 | CDK6 | 1.02738026 |
| 61 | CHUK | 0.98262894 |
| 62 | CAMKK2 | 0.97434199 |
| 63 | BLK | 0.96846402 |
| 64 | TAOK2 | 0.95461384 |
| 65 | BRSK2 | 0.95206434 |
| 66 | GRK6 | 0.94988765 |
| 67 | RIPK1 | 0.91732728 |
| 68 | ILK | 0.90969659 |
| 69 | FER | 0.90926459 |
| 70 | MAP3K3 | 0.89606305 |
| 71 | CLK1 | 0.88454314 |
| 72 | PIM1 | 0.86307525 |
| 73 | MAP3K8 | 0.86095828 |
| 74 | MAP3K5 | 0.85241832 |
| 75 | HCK | 0.82994271 |
| 76 | GRK5 | 0.82659820 |
| 77 | LIMK1 | 0.82633738 |
| 78 | PAK2 | 0.79368959 |
| 79 | ZAK | 0.78767316 |
| 80 | NEK2 | 0.78042423 |
| 81 | TXK | 0.78014501 |
| 82 | PAK1 | 0.77662358 |
| 83 | MAP3K10 | 0.77323117 |
| 84 | ERBB3 | 0.76751817 |
| 85 | PBK | 0.75474748 |
| 86 | LCK | 0.74236982 |
| 87 | PDGFRB | 0.71789651 |
| 88 | FGFR4 | 0.71642455 |
| 89 | TESK2 | 0.70185950 |
| 90 | EPHB2 | 0.69366595 |
| 91 | EIF2AK1 | 0.69056203 |
| 92 | DAPK3 | 0.68793270 |
| 93 | MST4 | 0.66829002 |
| 94 | RPS6KB2 | 0.66724600 |
| 95 | DDR2 | 0.66124834 |
| 96 | PLK2 | 0.65810885 |
| 97 | MARK3 | 0.64179946 |
| 98 | MAPK12 | 0.63490382 |
| 99 | PDK1 | 0.62973517 |
| 100 | IRAK3 | 0.62780584 |
| 101 | CDC7 | 0.62020682 |
| 102 | GRK7 | 0.60731982 |
| 103 | PDPK1 | 0.60105362 |
| 104 | LYN | 0.59615634 |
| 105 | ADRBK1 | 0.58830631 |
| 106 | RET | 0.55198616 |
| 107 | MAPKAPK2 | 0.55146700 |
| 108 | PRKG2 | 0.54346630 |
| 109 | FGFR2 | 0.52949940 |
| 110 | ABL2 | 0.52557216 |
| 111 | SYK | 0.50896040 |
| 112 | ACVR1B | 0.50091086 |
| 113 | IGF1R | 0.49773835 |
| 114 | CAMK1D | 0.48526195 |
| 115 | MKNK1 | 0.48232870 |
| 116 | STK24 | 0.48121687 |
| 117 | BMPR1B | 0.47944576 |
| 118 | YES1 | 0.47644422 |
| 119 | MATK | 0.47559795 |
| 120 | SIK1 | 0.46946831 |
| 121 | EGFR | 0.46919631 |
| 122 | JAK2 | 0.46704282 |
| 123 | MOS | 0.46270673 |
| 124 | NLK | 0.45824166 |
| 125 | PIK3CA | 0.45800014 |
| 126 | AURKB | 0.45493806 |
| 127 | PRKD1 | 0.45420883 |
| 128 | ABL1 | 0.44979769 |
| 129 | FGFR1 | 0.44781871 |
| 130 | SIK3 | 0.44464472 |
| 131 | PIK3CG | 0.43688929 |
| 132 | PRKCQ | 0.42796036 |
| 133 | PTK2 | 0.41366363 |
| 134 | MAP3K1 | 0.41085040 |
| 135 | MAP2K1 | 0.40021854 |
| 136 | PRKACG | 0.39548809 |
| 137 | MAP3K13 | 0.39006380 |
| 138 | CDC42BPA | 0.36642885 |
| 139 | ERBB2 | 0.35009657 |
| 140 | CAMK1G | 0.34134891 |
| 141 | FYN | 0.33962229 |
| 142 | PNCK | 0.33111913 |
| 143 | PRKCD | 0.31223162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52087436 |
| 2 | Viral myocarditis_Homo sapiens_hsa05416 | 2.17891977 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.05526409 |
| 4 | Malaria_Homo sapiens_hsa05144 | 1.99096948 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 1.96848979 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93090161 |
| 7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.84483650 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78719473 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.77896230 |
| 10 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.76864405 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74893211 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73080442 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.71418923 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.70094725 |
| 15 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.63539616 |
| 16 | Shigellosis_Homo sapiens_hsa05131 | 1.62375909 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.60923371 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60451898 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57615244 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57010457 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50874981 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48621769 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.48558367 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47997757 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.44938584 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44792545 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44588132 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.43789481 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.41781859 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39792838 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37886351 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34976942 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34161947 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.33587508 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.32171544 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.30296531 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.30056987 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.29901383 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.29275223 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28959363 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28545153 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.27357030 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.26438422 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.26292735 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23861631 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 1.23748476 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23300975 |
| 48 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.18019107 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.17630242 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16806007 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14968051 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10851749 |
| 53 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.10528207 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10103060 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09952323 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09853118 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 1.09333357 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06976578 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05138839 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04717226 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04511516 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 1.02733046 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01518058 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01386199 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00848746 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00682941 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97534091 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.94857393 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93917612 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.93718521 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92249774 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90038034 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89949154 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87616697 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85768088 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85360232 |
| 77 | Asthma_Homo sapiens_hsa05310 | 0.85347592 |
| 78 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.82952841 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82226175 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81935395 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80230043 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77446344 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77335304 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76319361 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.76277523 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.75715848 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74369603 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74203271 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73411030 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73240249 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73000608 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72217126 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.70214180 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68011254 |
| 95 | Mismatch repair_Homo sapiens_hsa03430 | 0.67133150 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65839984 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64738354 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64632078 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62787364 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62128868 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60817076 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59452077 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59440516 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58926322 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57633605 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.57105214 |
| 107 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57095866 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56781648 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55819362 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55636878 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.53293329 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53156645 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52755922 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52747705 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52476877 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50838972 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50445421 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50306222 |
| 119 | Proteasome_Homo sapiens_hsa03050 | 0.50175452 |
| 120 | Long-term depression_Homo sapiens_hsa04730 | 0.49483895 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49287387 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.47401987 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.46427358 |
| 124 | Ribosome_Homo sapiens_hsa03010 | 0.46339210 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46156806 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45945506 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44766407 |
| 128 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43022529 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43005152 |

